1-9 of 9
Jeffrey Schowinsky
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Venetoclax Plus Azacitidine for Newly Diagnosed Younger Acute Myeloid Leukemia Patients Independent of Fitness for Intensive Chemotherapy

Justin M. Watts, Connor Sohalski, Alessia Zoso, Jessica Dell-Martin, Ayele Belachew, Diana Abbott, Maria L Amaya, Andrew Kent, Christine M. McMahon, Marc Schwartz, Mikkael A. Sekeres, Clayton Smith, Sangeetha Venugopal, Craig T Jordan, Mary Berg, Mary Haag, Nicholas Willard, Dara Aisner, Jeffrey Schowinsky, Zenggang Pan, Jingjing Zhang, Jonathan Gutman, Daniel A Pollyea
Journal: Blood
Blood (2024) 144 (Supplement 1): 969.
https://doi.org/10.1182/blood-2024-199267
Published: 2024
Journal Articles

Omacetaxine and Azacitidine for Newly Diagnosed Patients with Myelodysplastic Syndromes and Excess Blasts

Daniel A Pollyea, Brett M Stevens, Diana Abbott, Maria L Amaya, Jonathan Gutman, Andrew Kent, Christine M. McMahon, Marc Schwartz, Clayton Smith, Jessica Dell-Martin, Connor Sohalski, Alexandra Ellis, Mary Haag, Jeffrey Schowinsky, Zenggang Pan, Sweta B Patel, Monica Ransom, Austin E Gillen, Eric M. Pietras, Craig T Jordan
Journal: Blood
Blood (2024) 144 (Supplement 1): 1828.
https://doi.org/10.1182/blood-2024-199336
Published: 2024
Journal Articles

Higher-Dose Venetoclax with Measurable Residual Disease-Guided Azacitidine Discontinuation in Newly Diagnosed Patients with Acute Myeloid Leukemia: Phase 2 Hiddav Study

Jonathan A. Gutman, Amanda C. Winters, Andrew Kent, Maria L. Amaya, Christine M. McMahon, Clayton Smith, Craig T Jordan, Brett M. Stevens, Mohammad Minhajuddin, Shanshan Pei, Jeffrey Schowinsky, Jennifer Tobin, Kelly O'Brien, Angela Falco, Elizabeth Taylor, Constance Brecl, Phuong Ho, Connor Sohalski, Jessica Dell-Martin, Olivia Ondracek, Diana Abbott, Daniel A. Pollyea
Journal: Blood
Blood (2022) 140 (Supplement 1): 3275–3276.
https://doi.org/10.1182/blood-2022-157802
Published: 2022
Journal Articles

Venetoclax and Azacitidine for Newly Diagnosed Non-Elderly Adult Patients with Acute Myeloid Leukemia and Adverse Risk Features

Jonathan A. Gutman, MD, Amanda Winters, MDPhD, Maria L Amaya, MD PhD, Christine M. McMahon, MD, Jeffrey Schowinsky, MD, Diana Abbott, PhD, Andrew Hammes, MS, Shanshan Pei, PhD, Brett M. Stevens, PhD, Craig T. Jordan, PhD, Clayton Smith, MD, Daniel A. Pollyea
Journal: Blood
Blood (2020) 136 (Supplement 1): 9.
https://doi.org/10.1182/blood-2020-136120
Published: 2020
Journal Articles

Developmental Plasticity of Acute Myeloid Leukemia Mediates Resistance to Venetoclax-Based Therapy

Shanshan Pei, PhD, Daniel A Pollyea, MD, Annika Gustafson, Mohammad Minhajuddin, PhD, Brett M. Stevens, PhD, Haobin Ye, PhD, Anagha Inguva, BSc, Maria L Amaya, MD PhD, Anna Krug, BS, Courtney L Jones, PhD, Biniam Adane, PhD, Amanda Winters, MD PhD, Nabilah Khan, Jessica Ponder, PhD, Jeffrey Schowinsky, Andrew Hammes, MS, Diana Abbott, PhD, Jason R Myers, MS, John M Ashton, PhD, Jonathan A Gutman, MD, Enkhtsetseg Purev, MD PhD, Haley E. Ramsey, PhDMSc, Michael R. Savona, MD, Stephen W. Fesik, PhD, Clayton Smith, MD, Craig T Jordan, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 185.
https://doi.org/10.1182/blood-2019-131390
Published: 2019
Journal Articles

Venetoclax and Azacitidine for Older Newly Diagnosed Patients with Acute Myeloid Leukemia: A Single-Institution Pilot Study Using Measurable Residual Disease to Guide Therapy

Amanda Winters, MD PhD, Jonathan A Gutman, MD, Enkhtsetseg Purev, MD PhD, Brett M. Stevens, PhD, Shanshan Pei, PhD, Jeffrey Schowinsky, Diana Abbott, PhD, Andrew Hammes, MS, Molly Nakic, Lindsey Lyle, Keri Halsema, Dwight Macero, PA-C, Alex Hirose, Chelsey Boggs, Angie Falco, Natalie Monson, Shirstine Rahkola, Sarah Wright, Tyler D'Ovidio, Clayton Smith, MD, Craig T Jordan, PhD, Daniel A Pollyea, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2638.
https://doi.org/10.1182/blood-2019-122120
Published: 2019
Journal Articles

Post-Transplant Diffuse Large B Cell Lymphoma with Non Germinal Center B-Cell Subtype Frequently Lacks Programmed Cell Death Ligand (PD-L1) Overexpression Which May Influence Overall Outcomes

Zohra Nooruddin, MD, Zenggang Pan, MD PhD, Lilyana Gross, Weitzenkamp David, Bradley M. Haverkos, MD MPH, MS, Daniel A Pollyea, MD, Jonathan A Gutman, MD, William Robinson, MD PhD, Clayton Smith, MD FRCPC, Jeffrey Schowinsky, MD, Purev Enkhtsetseg, MD, Daniel W. Sherbenou, MD PhD, Rachel Rabinovitch, MD, Douglas Ney, MD, Craig T Jordan, PhD, Manali Kamdar, MD
Journal: Blood
Blood (2016) 128 (22): 3054.
https://doi.org/10.1182/blood.V128.22.3054.3054
Published: 2016
Journal Articles

IHC Analysis and Prognostic Factors in Post Transplant Lymphoproliferative Disorders after Solid Organ Transplantation: A Single Center Experience

Zohra Nooruddin, MD, William Robinson, MD PhD, Daniel Pollyea, MD MS, Jonathan A Gutman, MD, Clayton Smith, MD FRCPC, Zenggang Pan, MD, Craig T Jordan, PhD, Rachel Rabinovitch, MD, Jeffrey Schowinsky, Xian Lu, PhD, Douglas Ney, MD, Manali Kamdar, MD
Journal: Blood
Blood (2015) 126 (23): 1443.
https://doi.org/10.1182/blood.V126.23.1443.1443
Published: 2015
Journal Articles

Novel Description of Prospective Diagnosis of Congenital Acute Leukemia On Initial Processing of Banked Umbilical Cord Blood and Potential Implications for Testing Laboratories

Garth Aasen, MD, Micah Will, MD, Xiayuan Liang, MD, Jeffrey Schowinsky, MD
Journal: Blood
Blood (2012) 120 (21): 4129.
https://doi.org/10.1182/blood.V120.21.4129.4129
Published: 2012